599 filings
Page 4 of 30
6-K
39cufckyslk6
31 Mar 22
Portage Biotech Provides Update on Clinical-Stage and Development Programs
8:00am
UPLOAD
d6g1d0grpkzw217ur4
14 Mar 22
Letter from SEC
12:00am
20-F/A
go7e2aypkwrhfxard5m2
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
18hs8i8
25 Feb 22
Current report (foreign)
5:29pm
6-K
s58ip8n
25 Feb 22
Portage Biotech Announces Financial Results and Provides Business Update for Third Quarter of 2022 Fiscal Year
12:00am
UPLOAD
7h23195kl79ourn659es
17 Feb 22
Letter from SEC
12:00am
6-K
y4tzalcpsxfoxts
15 Feb 22
Portage Biotech Announces New Appointments to its Management Team and Board of Directors
8:00am
6-K
7n0tnk
23 Nov 21
Current report (foreign)
4:30pm
6-K
c7ishmoc0azrx5
23 Nov 21
Portage Biotech Announces Financial Results and Provides Business Update for Second Quarter of 2022 Fiscal Year
8:00am
6-K
slwyie0i2cstrcva vb0
30 Aug 21
Current report (foreign)
5:21pm
6-K
pe0a4z0igkxfppwp
30 Aug 21
Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year
8:00am
6-K
3farwjxm9593 74cm6
12 Aug 21
Portage Biotech Issues Letter to Shareholders
10:01am
6-K
6tr565n 11q
28 Jul 21
Current report (foreign)
9:37am
SUPPL
edsfy cm4rh70zxnw83
24 Jun 21
Supplemental materials (foreign)
5:27pm
6-K
ik37rj47
24 Jun 21
Portage Biotech Inc. Announces Proposed Offering of Ordinary Shares
4:05pm
SUPPL
8tumtfyywetrlfuge
23 Jun 21
Supplemental materials (foreign)
4:01pm
20-F/A
0qt pprxw
26 Mar 21
Annual report (foreign) (amended)
12:00am
EFFECT
ni3utd8aerq6usjg8rk
9 Mar 21
Notice of effectiveness
12:15am
424B5
1osca itomaifwls
8 Mar 21
Prospectus supplement for primary offering
5:03pm